Vernier Capital Partners’s CVS Health CVS Stock Holding History

Vernier Capital Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-148,000	Closed	-$9.7M	–	25
2018 Q4	$9.7M	Buy	148,000 +38,040	+35%	+$2.84M	6.35%	6
2018 Q3	$8.66M	Buy	109,960 +28,544	+35%	+$2.04M	3.86%	10
2018 Q2	$5.24M	Sell	81,416 -83,084	-51%	-$5.48M	2.37%	19
2018 Q1	$10.2M	Buy	164,500 +77,000	+88%	+$5.52M	6.08%	6
2017 Q4	$6.34M	Buy	+87,500	New	+$6.36M	3.39%	16
2017 Q1	–	Sell	-112,900	Closed	-$8.91M	–	21
2016 Q4	$8.91M	Buy	112,900 +6,030	+6%	+$488K	4.96%	11
2016 Q3	$9.51M	Sell	106,870 -84,630	-44%	-$7.99M	2.45%	11
2016 Q2	$18.3M	Buy	191,500 +45,000	+31%	+$4.48M	5.16%	8
2016 Q1	$15.2M	Buy	+146,500	New	+$14.2M	6.59%	5

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vernier Capital Partners's CVS Position: Q1 2019 in Review

Vernier Capital Partners sold out of CVS Health (CVS) in Q1 2019, closing a stake of 148,000 shares — an estimated $9.7M sold.

Vernier Capital Partners first reported a position in CVS in Q1 2016 and held it in 9 quarters. The position peaked at $18.3M in Q2 2016. 1,708 funds tracked by Wall St. Rank hold CVS as of Q1 2019.

Vernier Capital Partners reported no remaining CVS Health position as of Q1 2019 after selling out during the quarter.
Vernier Capital Partners sold 148,000 CVS Health shares in Q1 2019, an estimated $9.7M.
Vernier Capital Partners first reported a position in CVS Health in Q1 2016 and held it in 9 quarters.
Vernier Capital Partners's CVS Health position peaked at $18.3M in Q2 2016.
1,708 funds tracked by Wall St. Rank held CVS Health as of Q1 2019.

Based on Vernier Capital Partners's 13F filing for Q1 2019, filed 15 May 2019.